Access cutting-edge melanoma treatment through this clinical trial at a research site in Los Angeles. Study-provided care at no cost to qualified participants.
Access melanoma specialists in Los Angeles at no cost
This study follows strict safety protocols and ethical guidelines
All study-related melanoma treatment provided free
This clinical trial is a prospective, multicenter, open-label, randomized, actively controlled, parallel-group Phase 3 clinical trial to evaluate the efficacy, safety and tolerability of treatment with IMA203 administered at the recommended phase 2 dose versus investigator's choice of treatment in patients with previously treated, unresectable or metastatic cutaneous melanoma.
Sponsor: Immatics US, Inc.
Check if you qualify for this melanoma clinical trial in Los Angeles, CA
If you're searching for melanoma treatment options in Los Angeles, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Los Angeles research site is actively enrolling participants for this clinical trial. You'll receive care from experienced melanoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.